Brief: Aprea Therapeutics Inc - Expects Cash And Cash Equivalents Of $50.0 Million To $55.0 Million (Unaudited) As Of Dec 31, 2021
Jan 13 (Reuters) - Aprea Therapeutics Inc APRE.O :
* APREA THERAPEUTICS INC - EXPECTS CASH AND CASH EQUIVALENTS
OF
$50.0 MILLION TO $55.0 MILLION (UNAUDITED) AS OF DEC 31, 2021
Further company coverage: APRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aprea Therapeutics
See all newsAprea Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aprea Therapeutics Q2 net loss widens on higher R&D costs
Aprea Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
Brief: Aprea Therapeutics - Files For Resale Of Up To 5.5 Million Shares By Selling Stockholders - SEC Filing